Metastatic non small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up.
S. Novello1, F. Barlesi2, R. Califano3,4, T. Cufer5, S. Ekman6, M. Giaj Levra7, K. Kerr8, S. Popat9, M. Reck10, S. Senan11, G. V. Simo12, J. Vansteenkiste13 S. Peters14 on behalf of the ESMO Guidelines Committee* Oncology Department, University of Turin, AOU San Luigi Orbassano, Orbassano, Italy; Assistance Publique Hopitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, Marseille, France; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Department of Medical Oncology, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK; Medical Faculty Ljubljana, University Clinic Golnik, Golnik, Slovenia; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Thoracic Oncology Unit, Centre Hospitalier Universitaire Grenoble Alpes (CHUGA) Grenoble, France; Department of Pathology, Aberdeen University Medical School, Aberdeen Royal Infirmary, Aberdeen; Department of Medicine, Royal Marsden Hospital, London, UK; Department of Thoracic Oncology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN) Member of the German Centre for Lung Research (DZL) Grosshansdorf, Germany; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands; Thoracic Surgery Service, Salamanca University Hospital, Salamanca, Spain; Respiratory Oncology Unit (Pulmonology) University Hospital KU Leuven, Leuven, Belgium; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland
Annals of oncology official journal of the European Society for Medical Oncology